Skip to content

Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19)

Clinical Study on Syndrome Differentiation of TCM in Treating Severe and Critical novel coronavirus pneumonia (COVID-19)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000003050
Enrollment
Unknown
Registered
2020-02-24
Start date
2020-02-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Sponsors

Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Comply with the diagnostic criteria for COVID-19 in the "Diagnosis and Treatment Program for pneumonia caused by novel coronavirus infection (Trial Version 5)", meet the the criteria of severe and critical type; (2) Agree to participate in the study and the patient or legal guardian signs the informed consent form.

Exclusion criteria

Exclusion criteria: (1) It is difficult to administer to patients by oral or nasal feeding; (2) Pregnant women, as well as patients with other malignancies such as malignant tumors, mental illnesses, and patients who are not considered suitable for study.

Design outcomes

Primary

MeasureTime frame
Cure / mortality rate;Becomes negative time of COVID-19;TCM symptom score;

Secondary

MeasureTime frame
Indicators of inflammation (CRP, ESR);Blood gas analysis;Chest CT;Major symptom relief time;

Countries

China

Contacts

Public ContactDonghui Huang

Guangdong Provincial Hospital of Chinese Medicine - Zhuhai Hospital

13600001163@139.com+86 0756-3325892

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026